Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP124452.RA-_1eSg-Zectz1NYHh25UGxyr8xGTi0Nydj_nxtjFbaQ130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP124452.RA-_1eSg-Zectz1NYHh25UGxyr8xGTi0Nydj_nxtjFbaQ130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP124452.RA-_1eSg-Zectz1NYHh25UGxyr8xGTi0Nydj_nxtjFbaQ130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP124452.RA-_1eSg-Zectz1NYHh25UGxyr8xGTi0Nydj_nxtjFbaQ130_provenance.
- gad-20150221 importedOn "2015-02-21" NP124452.RA-_1eSg-Zectz1NYHh25UGxyr8xGTi0Nydj_nxtjFbaQ130_provenance.
- NP124452.RA-_1eSg-Zectz1NYHh25UGxyr8xGTi0Nydj_nxtjFbaQ130_assertion wasGeneratedBy ECO_0000203 NP124452.RA-_1eSg-Zectz1NYHh25UGxyr8xGTi0Nydj_nxtjFbaQ130_provenance.
- NP124452.RA-_1eSg-Zectz1NYHh25UGxyr8xGTi0Nydj_nxtjFbaQ130_assertion wasDerivedFrom gad-20150221 NP124452.RA-_1eSg-Zectz1NYHh25UGxyr8xGTi0Nydj_nxtjFbaQ130_provenance.
- NP124452.RA-_1eSg-Zectz1NYHh25UGxyr8xGTi0Nydj_nxtjFbaQ130_assertion SIO_000772 19553641 NP124452.RA-_1eSg-Zectz1NYHh25UGxyr8xGTi0Nydj_nxtjFbaQ130_provenance.
- NP124452.RA-_1eSg-Zectz1NYHh25UGxyr8xGTi0Nydj_nxtjFbaQ130_assertion evidence source_evidence_literature NP124452.RA-_1eSg-Zectz1NYHh25UGxyr8xGTi0Nydj_nxtjFbaQ130_provenance.
- NP124452.RA-_1eSg-Zectz1NYHh25UGxyr8xGTi0Nydj_nxtjFbaQ130_assertion description "[Olaparib has few of the adverse effects of conventional chemotherapy, inhibits PARP, and has antitumor activity in cancer associated with the BRCA1 or BRCA2 mutation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP124452.RA-_1eSg-Zectz1NYHh25UGxyr8xGTi0Nydj_nxtjFbaQ130_provenance.